(PharmaNewsWire.Com, April 28, 2017 ) Middle-East and Africa Insulin Delivery Devices Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 8.55% to reach USD 1.62 Billion by 2021, from USD 1.08 Billion in 2016.
Insulin is an essential part of the treatment plan for all people with Type 1 diabetes and many with Type 2. Insulin helps get glucose and maintain sugar levels from the bloodstream into the fat and muscle cells. It cannot be taken as a pill or a swallowed liquid, as it would be effect the digestive system before it reached the bloodcell, where insulin does its work in blood stream. Therefore, insulin is injected into the fatty tissue under the skin using syringes.
The development of insulin delivery devices has been encouraged from the past years. These insulin delivery devices are used to deliver the insulin doses travel via parenteral route rather than oral route of administration. Insulin delivery devices promote absorption rate of insulin into blood stream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.
Key factors, that affects and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are Growing aging population Increasing incident rate of diabetes among the population Rising government initiatives towards the diabetes Growing awareness among the diabetes patients are some of the factors driving the growth of insulin delivery devices market in Middle East and Africa Insufficient healthcare infrastructure to maintain the advanced insulin delivery devices, Inadequate number of physicians Unavailability of social and economic facilities are expected to restrain the growth.
For granular level understanding the Middle-East and Africa Insulin Delivery Devices Market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Introduction Type I Diabetes Type II Diabetes
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, KSA, UAE, Nigeria and Algeria.
The key players in insulin delivery devices market such as, Becton, Dickinson and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.).
The Middle-East and Africa Insulin Delivery Devices Market report offers wide-range of scope: Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of crop type, and application along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
For more reports related to the Insulin Delivery Devices Market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
